Iron Triangle Partners LP - Q1 2023 holdings

$693 Million is the total value of Iron Triangle Partners LP's 27 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .

 Value Shares↓ Weighting
ABBV NewABBVIE INC$50,998,400320,000
+100.0%
7.36%
UNH NewUNITEDHEALTH GROUP INC$37,807,20080,000
+100.0%
5.45%
EVH NewEVOLENT HEALTH INCcl a$32,463,0451,000,402
+100.0%
4.68%
IDXX NewIDEXX LABS INC$25,004,00050,000
+100.0%
3.61%
LEGN NewLEGEND BIOTECH CORPsponsored ads$24,110,000500,000
+100.0%
3.48%
TXG New10X GENOMICS INC$19,526,500350,000
+100.0%
2.82%
SDGR NewSCHRODINGER INC$15,684,702595,697
+100.0%
2.26%
CUTR NewCUTERA INC$14,172,000600,000
+100.0%
2.04%
OLK NewOLINK HLDG ABsponsored ads$9,012,000400,000
+100.0%
1.30%
New2SEVENTY BIO INC$8,863,178868,939
+100.0%
1.28%
SWTX NewSPRINGWORKS THERAPEUTICS INC$8,047,971312,664
+100.0%
1.16%
BKD NewBROOKDALE SR LIVING INC$7,965,0002,700,000
+100.0%
1.15%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings